These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 31667615

  • 1. Clinicopathological features of C3 glomerulopathy in children: a single-center experience.
    Drake KA, Ellington N, Gattineni J, Torrealba JR, Hendricks AR.
    Pediatr Nephrol; 2020 Jan; 35(1):153-162. PubMed ID: 31667615
    [Abstract] [Full Text] [Related]

  • 2. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
    Viswanathan GK, Nada R, Kumar A, Ramachandran R, Rayat CS, Jha V, Sakhuja V, Joshi K.
    Diagn Pathol; 2015 Mar 17; 10():6. PubMed ID: 25889427
    [Abstract] [Full Text] [Related]

  • 3. Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
    Holle J, Berenberg-Goßler L, Wu K, Beringer O, Kropp F, Müller D, Thumfart J.
    Pediatr Nephrol; 2018 Dec 17; 33(12):2289-2298. PubMed ID: 30238151
    [Abstract] [Full Text] [Related]

  • 4. C3 glomerulonephritis with a severe crescentic phenotype.
    Ravindran A, Fervenza FC, Smith RJH, Sethi S.
    Pediatr Nephrol; 2017 Sep 17; 32(9):1625-1633. PubMed ID: 28593446
    [Abstract] [Full Text] [Related]

  • 5. Defining the complement biomarker profile of C3 glomerulopathy.
    Zhang Y, Nester CM, Martin B, Skjoedt MO, Meyer NC, Shao D, Borsa N, Palarasah Y, Smith RJ.
    Clin J Am Soc Nephrol; 2014 Nov 07; 9(11):1876-82. PubMed ID: 25341722
    [Abstract] [Full Text] [Related]

  • 6. C3 glomerulopathy and current dilemmas.
    Ito N, Ohashi R, Nagata M.
    Clin Exp Nephrol; 2017 Aug 07; 21(4):541-551. PubMed ID: 27878657
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
    Bomback AS, Santoriello D, Avasare RS, Regunathan-Shenk R, Canetta PA, Ahn W, Radhakrishnan J, Marasa M, Rosenstiel PE, Herlitz LC, Markowitz GS, D'Agati VD, Appel GB.
    Kidney Int; 2018 Apr 07; 93(4):977-985. PubMed ID: 29310824
    [Abstract] [Full Text] [Related]

  • 9. Clinical characteristics and outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulopathy in Japanese children.
    Ueda C, Horinouchi T, Inoki Y, Ichikawa Y, Tanaka Y, Kitakado H, Kondo A, Sakakibara N, Nagano C, Yamamura T, Fujimura J, Kamiyoshi N, Ishimori S, Ninchoji T, Kaito H, Shima Y, Iijima K, Nozu K, Yoshikawa N.
    Pediatr Nephrol; 2024 Sep 07; 39(9):2679-2689. PubMed ID: 38662234
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohort.
    Michels MAHM, Wijnsma KL, Kurvers RAJ, Westra D, Schreuder MF, van Wijk JAE, Bouts AHM, Gracchi V, Engels FAPT, Keijzer-Veen MG, Dorresteijn EM, Volokhina EB, van den Heuvel LPWJ, van de Kar NCAJ.
    Pediatr Nephrol; 2022 Mar 07; 37(3):601-612. PubMed ID: 34476601
    [Abstract] [Full Text] [Related]

  • 12. C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis.
    Xiao X, Pickering MC, Smith RJ.
    Semin Thromb Hemost; 2014 Jun 07; 40(4):465-71. PubMed ID: 24799308
    [Abstract] [Full Text] [Related]

  • 13. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
    Sethi S, Fervenza FC, Zhang Y, Zand L, Vrana JA, Nasr SH, Theis JD, Dogan A, Smith RJ.
    Kidney Int; 2012 Aug 07; 82(4):465-73. PubMed ID: 22673887
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathy.
    Madden B, Singh RD, Haas M, Palma LMP, Sharma A, Vargas MJ, Gross L, Negron V, Nate T, Charlesworth MC, Theis JD, Nasr SH, Nath KA, Fervenza FC, Sethi S.
    Kidney Int; 2024 May 07; 105(5):1077-1087. PubMed ID: 38447879
    [Abstract] [Full Text] [Related]

  • 15. Kidney Transplantation in C3 Glomerulopathy: A Case Series.
    Regunathan-Shenk R, Avasare RS, Ahn W, Canetta PA, Cohen DJ, Appel GB, Bomback AS.
    Am J Kidney Dis; 2019 Mar 07; 73(3):316-323. PubMed ID: 30413277
    [Abstract] [Full Text] [Related]

  • 16. C3 glomerulopathy associated with monoclonal Ig is a distinct subtype.
    Ravindran A, Fervenza FC, Smith RJH, Sethi S.
    Kidney Int; 2018 Jul 07; 94(1):178-186. PubMed ID: 29729982
    [Abstract] [Full Text] [Related]

  • 17. Dense deposit disease in a child with febrile sore throat.
    Conti G, De Vivo D, Vitale A, Fede C, Santoro D.
    Saudi J Kidney Dis Transpl; 2017 Jul 07; 28(4):925-928. PubMed ID: 28748900
    [Abstract] [Full Text] [Related]

  • 18. C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.
    Zhang Y, Meyer NC, Fervenza FC, Lau W, Keenan A, Cara-Fuentes G, Shao D, Akber A, Fremeaux-Bacchi V, Sethi S, Nester CM, Smith RJH.
    Am J Kidney Dis; 2017 Dec 07; 70(6):834-843. PubMed ID: 28838767
    [Abstract] [Full Text] [Related]

  • 19. C3 nephritic factor associated with C3 glomerulopathy in children.
    Nicolas C, Vuiblet V, Baudouin V, Macher MA, Vrillon I, Biebuyck-Gouge N, Dehennault M, Gié S, Morin D, Nivet H, Nobili F, Ulinski T, Ranchin B, Marinozzi MC, Ngo S, Frémeaux-Bacchi V, Pietrement C.
    Pediatr Nephrol; 2014 Jan 07; 29(1):85-94. PubMed ID: 24068526
    [Abstract] [Full Text] [Related]

  • 20. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
    Servais A, Noël LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grünfeld JP, Niaudet P, Lesavre P, Frémeaux-Bacchi V.
    Kidney Int; 2012 Aug 07; 82(4):454-64. PubMed ID: 22456601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.